Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Nov 2006

Cozen Wendy, Gebregziabher Mulugeta, Conti David V, Van Den Berg David J, Coetzee Gerhard A, Wang Sophia S, Rothman Nathaniel, Bernstein Leslie, Hartge Patricia, Morhbacher Ann, Coetzee Simon G, Salam Muhammad T, Wang Wei, Zadnick John, Ingles Sue A

Abstract excerpt

Interleukin-6 (IL-6) promotes normal plasma cell development and proliferation of myeloma cells in culture. We evaluated IL-6 genotypes and body mass index (BMI) in a case-control study of multiple myeloma and plasmacytoma. DNA samples and questionnaires were obtained from incident cases of multi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Mass Index

Share to Case-Control Studies

Share to Genetic Variation

Share to Interleukin-6

Share to Multiple Myeloma

Share to Plasmacytoma

Source

Identifiers

PMID: 17119059
DOI: 10.1158/1055-9965.EPI-06-0446

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17119059-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.PMID 17119059Read ↗

Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.Semantic proximity Read ↗

Interleukin-6 gene-174 G/C promoter polymorphism and its association with clinical profile of patients with multiple myeloma.Semantic proximity Read ↗

Interleukin-6 polymorphisms and hematologic malignancy: a re-appraisal of evidence from genetic association studies.Semantic proximity Read ↗

Association of IL-6 Promoter and Receptor Polymorphisms with Multiple Myeloma Risk: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Interleukin-6 gene-174 G/C promoter polymorphism is not associated with multiple myeloma susceptibility: evidence from meta-analysis: A systematic review and meta-analysis.Semantic proximity Read ↗

Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.Semantic proximity Read ↗

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.Semantic proximity Read ↗

Analysis of polymorphism at site -174 G/C of interleukin-6 promoter region in multiple myeloma.Semantic proximity Read ↗

Role of cytokines in multiple myeloma: IL-1RN and IL-4 VNTR polymorphisms.Semantic proximity Read ↗

IL-6 polymorphism, anti-IL-6 therapy and animal models of multiple myeloma.Semantic proximity Read ↗

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.Semantic proximity Read ↗

Search for multiple myeloma risk factors using Mendelian randomization.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.